Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer

Que, Y; Wang, J; Zhu, J; Li, N; Huang, JT; Lu, SY; Sun, FF; Zhang, L; Zhen, ZJ; Zhang, L; Cai, RQ; Guo, HX; Sun, XF; Zhang, YZ

Sun, XF; Zhang, YZ (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China.; Sun, XF; Zhang, YZ (corresponding author), Sun Yat Sen Univ, Dept Pediat Oncol, Canc Ctr, Guangzhou, Peoples R China.; Guo, HX (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pediat, Guangzhou, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2021; 12 ():

Abstract

There is limited experience of PD-1 antibody combined with other therapies in children. We aimed to explore the antitumor activity and safety of PD-1 ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索